Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands-Reference-Cited by-同舟云学术

Significant inter- and intra-laboratory variation in grading of ductal carcinoma in situ of the breast: a nationwide study of 4901 patients in the Netherlands

Published:2018-12-11 Issue:2 Volume:174 Page:479-488
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

van Dooijeweert Carmen,van Diest Paul J.^ORCID,Willems Stefan M.,Kuijpers Chantal C. H. J.,Overbeek Lucy I. H.,Deckers Ivette A. G.

Funder

The Quality Foundation of the Dutch Association of Medical Specialists

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10549-018-05082-y.pdf

Reference29 articles.

1. Pinder SE, Ellis IO (2003) The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)—current definitions and classification. Breast Cancer Res 5(5):254–257

2. Welch HG, Black WC (1997) Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast: how much more breast cancer can we find? Ann of Intern Med 127(11):1023–1028

3. Francis A, Thomas J, Fallowfield L et al (2015) Addressing overtreatment of screen detected DCIS; the LORIS trial. Eur J Cancer 51(16):2296–2303

4. Elshof LE, Tryfonidis K, Slaets L et al (2015) Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ—the LORD study. Eur J Cancer 51(12):1497–1510

5. Benson JR, Jatoi I, Toi M (2016) Treatment of low-risk ductal carcinoma in situ: is nothing better than something? Lancet Oncol 17(10):e442–e451

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive model for laser-induced tissue necrosis with immunohistochemistry validation;Biophotonics Discovery;2024-08-05

2. Invasive recurrence after breast conserving treatment of ductal carcinoma in situ of the breast in the Netherlands: time trends and the association with tumour grade;British Journal of Cancer;2024-07-09

3. Pros and cons of artificial intelligence implementation in diagnostic pathology;Histopathology;2024-03-03

4. Deep‐learning model to improve histological grading and predict upstaging of atypical ductal hyperplasia / ductal carcinoma in situ on breast biopsy;Histopathology;2024-01-30

5. Update on Management of Ductal Carcinoma in Situ;Clinical Breast Cancer;2023-12